NCT02451358View on ClinicalTrials.gov

Study of a Single Dose or Two Doses of a Quadrivalent Influenza Vaccine in Subjects Aged 6 Months or Older in India

PHASE3CompletedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

July 27, 2015

Primary Completion Date

January 28, 2017

Study Completion Date

January 28, 2017

Conditions
Influenza
Interventions
BIOLOGICAL

Quadrivalent Inactivated Influenza Vaccine (2016-2017 NH formulation), No Preservative

0.25 mL, Intramuscular

BIOLOGICAL

Quadrivalent Inactivated Influenza Vaccine (2016 SH formulation), No Preservative

0.5 mL, Intramuscular

BIOLOGICAL

Quadrivalent Inactivated Influenza Vaccine (2015-2016 NH formulation), No Preservative

0.5 mL, Intramuscular

BIOLOGICAL

Quadrivalent Inactivated Influenza Vaccine (2015 SH formulation), No Preservative

0.5 mL, Intramuscular

Trial Locations (8)

141008

Ludhiana

390001

Vadodara

400012

Mumbai

411018

Pimpri

411043

Pune

560054

Bangalore

571401

Mandya

700017

Kolkata

All Listed Sponsors
lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY

NCT02451358 - Study of a Single Dose or Two Doses of a Quadrivalent Influenza Vaccine in Subjects Aged 6 Months or Older in India | Biotech Hunter | Biotech Hunter